Y-mAbs Therapeutics Inc
NASDAQ:YMAB

Watchlist Manager
Y-mAbs Therapeutics Inc Logo
Y-mAbs Therapeutics Inc
NASDAQ:YMAB
Watchlist
Price: 10.41 USD 3.07% Market Closed
Market Cap: 464m USD
Have any thoughts about
Y-mAbs Therapeutics Inc?
Write Note

Cash Flow Statement

Cash Flow Statement
Y-mAbs Therapeutics Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Operating Cash Flow
Net Income
(27)
(31)
(38)
(43)
(52)
(59)
(72)
(81)
(91)
(114)
(123)
(119)
(60)
(42)
(38)
(55)
(117)
(135)
(134)
(96)
(74)
(39)
(19)
(21)
(22)
(25)
(24)
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Stock-Based Compensation
1
2
2
2
3
3
4
5
6
7
9
16
19
21
23
19
20
29
27
26
26
16
15
14
13
13
0
Other Non-Cash Items
1
1
2
2
3
3
4
5
6
16
18
24
(35)
(41)
(39)
(41)
22
32
32
29
29
17
14
13
13
13
13
Cash Taxes Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Change in Working Capital
3
2
3
(0)
1
6
6
3
3
2
6
3
(7)
(10)
(10)
(7)
(1)
3
(0)
(10)
(20)
(24)
(24)
(20)
(9)
(2)
(12)
Cash from Operating Activities
(22)
N/A
(27)
-22%
(34)
-24%
(41)
-21%
(48)
-17%
(50)
-5%
(63)
-24%
(74)
-18%
(82)
-11%
(95)
-17%
(98)
-3%
(91)
+7%
(101)
-11%
(92)
+9%
(86)
+7%
(103)
-19%
(96)
+7%
(100)
-5%
(101)
-1%
(76)
+25%
(64)
+16%
(46)
+29%
(28)
+39%
(27)
+2%
(18)
+35%
(13)
+29%
(22)
-74%
Investing Cash Flow
Capital Expenditures
0
(0)
(0)
(0)
(0)
(0)
(1)
(2)
(2)
(2)
(1)
(0)
(1)
(1)
(1)
(1)
(1)
(1)
(0)
0
0
0
0
0
0
0
0
Other Items
0
0
0
0
0
0
0
0
0
0
(3)
(3)
59
59
62
62
0
0
0
0
0
0
0
0
0
0
0
Cash from Investing Activities
0
N/A
(0)
N/A
(0)
-50%
(0)
-28%
(0)
-57%
(0)
+14%
(1)
-181%
(2)
-126%
(2)
+5%
(2)
+4%
(4)
-116%
(3)
+28%
59
N/A
59
0%
61
+4%
61
-1%
(1)
N/A
(1)
+7%
(0)
+13%
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
Financing Cash Flow
Net Issuance of Common Stock
0
79
167
100
0
0
(2)
135
135
135
135
2
109
110
110
108
1
0
0
0
0
0
0
0
1
2
3
Other
(2)
(1)
(1)
(1)
1
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Cash from Financing Activities
88
N/A
78
-12%
166
+113%
99
-40%
100
+2%
101
+0%
(2)
N/A
135
N/A
135
+0%
135
N/A
135
+0%
2
-99%
109
+5 374%
110
+0%
110
+0%
108
-1%
1
-100%
0
-26%
0
-51%
0
-56%
0
-38%
0
N/A
0
N/A
0
N/A
1
+588%
2
+256%
3
+40%
Change in Cash
Effect of Foreign Exchange Rates
(0)
0
0
0
0
0
0
0
0
(0)
(0)
(0)
(0)
(0)
(0)
0
0
0
0
0
(0)
(0)
(0)
0
0
(0)
0
Net Change in Cash
65
N/A
50
-23%
132
+163%
57
-56%
52
-9%
50
-4%
(65)
N/A
59
N/A
51
-13%
38
-26%
33
-13%
(93)
N/A
67
N/A
76
+14%
84
+12%
67
-21%
(96)
N/A
(100)
-5%
(101)
-1%
(76)
+25%
(64)
+15%
(46)
+29%
(28)
+39%
(27)
+3%
(17)
+38%
(10)
+40%
(18)
-83%
Free Cash Flow
Free Cash Flow
(22)
N/A
(28)
-23%
(34)
-24%
(41)
-21%
(48)
-17%
(51)
-4%
(63)
-25%
(75)
-19%
(84)
-11%
(97)
-16%
(99)
-2%
(91)
+8%
(102)
-11%
(93)
+9%
(87)
+7%
(104)
-19%
(96)
+7%
(101)
-4%
(102)
-1%
(76)
+25%
(64)
+16%
(46)
+29%
(28)
+39%
(27)
+2%
(18)
+35%
(13)
+29%
(22)
-74%

See Also

Discover More